Related Experiment Video

Updated: Jul 7, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis in children

Ben J Marais1

  • 1Department of Paediatrics and Child Health and the Desmond Tutu TB Centre, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa. bjmarais @sun.ac.za

Pediatric Pulmonology
|February 29, 2008
PubMed

Insights

Childhood tuberculosis (TB) remains a significant global health issue, especially in resource-limited areas. This review highlights advances in TB diagnosis, prevention, and treatment for children, focusing on intrathoracic manifestations.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Tuberculosis (TB) presents a major global health challenge, particularly impacting children in endemic regions.
  • Despite effective treatments, accurate diagnosis and child-friendly care for pediatric TB are difficult in resource-limited settings.
  • Intrathoracic TB manifestations in children contribute significantly to morbidity and mortality.

Purpose of the Study:

  • To provide a comprehensive overview of recent advancements in pediatric tuberculosis.
  • To focus on intrathoracic disease manifestations in children with TB.
  • To summarize current knowledge and introduce novel concepts for future TB research and evaluation.

Main Methods:

  • This study is a review of recent literature on childhood tuberculosis.
  • The review focuses on epidemiological data, prevention strategies, diagnostic methods, and treatment approaches.
  • Novel concepts and future research directions are also discussed.

Main Results:

  • Recent advances have been made in understanding and managing childhood TB.
  • Challenges persist in diagnosis and delivering supervised, child-friendly treatment in resource-limited settings.
  • Intrathoracic TB manifestations require specific attention in pediatric populations.

Conclusions:

  • Continued research and innovative strategies are crucial for improving TB control in children.
  • Addressing diagnostic and treatment access barriers is essential for reducing childhood TB burden.
  • Future evaluations should consider novel approaches to combat pediatric tuberculosis effectively.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: